JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tzen, K.-Y.
Right arrow Articles by Ting, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzen, K.-Y.
Right arrow Articles by Ting, G.

Differential Diagnosis of Parkinson’s Disease and Vascular Parkinsonism by 99mTc-TRODAT-1

Kai-Yuan Tzen, Chin-Song Lu, Tzu-Chen Yen, Shiaw-Pyng Wey and Gann Ting

Departments of Nuclear Medicine and Neurology, Chang Gung Memorial Hospital at Lin-Ko and Keelung, Taipei Medical Center and School of Medicine, Chang Gung University; and Institute of Nuclear Energy Research, Lung-Tan, Taiwan



View larger version (144K):

[in a new window]
 
FIGURE 1. (A) 99mTc-TRODAT-1 brain SPECT and MR images of 62-y-old male VP patient. Symmetric and normal uptake of 99mTc-TRODAT-1 in bilateral basal ganglia is observed (L = left image). Multiple small infarcts are seen bilaterally in basal ganglia and white matter (arrow) on MR image (R = right image). (B) 99mTc-TRODAT-1 brain SPECT and MR images of 62-y-old male Parkinson’s disease patient. Asymmetric and low uptake of 9mTc-TRODAT-1 in right putamen is observed (L = left image). No obvious abnormality is seen bilaterally in basal ganglia and white matter on MR image (R = right image).

 


View larger version (12K):

[in a new window]
 
FIGURE 2. 99mTc-TRODAT-1 uptake ratios in striatum in age-matched healthy (normal) individuals, VP patients, and Parkinson’s disease (PD) patients. Age-related decline of 99mTc-TRODAT-1 uptake ratios in striatum was observed in healthy individuals and in VP patients. In comparison with VP and Parkinson’s disease patients, 99mTc-TRODAT-1 uptake ratio in striatum is asymmetric and significantly decreased bilaterally in Parkinson’s disease patients. S/O ratio = striatum-to-occipital ratio.

 


View larger version (12K):

[in a new window]
 
FIGURE 3. Putamen-to-caudate uptake ratio (P/C ratio) for 99mTc-TRODAT-1 in age-matched VP and Parkinson’s disease (PD) patients. 99mTc-TRODAT-1 uptake in Parkinson’s disease patients is significantly decreased compared with that in VP patients, with uptake in contralateral putamen site more obviously decreased in Parkinson’s disease patients.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.